Telomerase reverse transcriptase acts in a feedback loop with NF-κB pathway to regulate macrophage polarization in alcoholic liver disease
- PMID: 26725521
- PMCID: PMC4698632
- DOI: 10.1038/srep18685
Telomerase reverse transcriptase acts in a feedback loop with NF-κB pathway to regulate macrophage polarization in alcoholic liver disease
Abstract
Activation of Kupffer cells (KCs) plays a central role in the pathogenesis of alcoholic liver disease (ALD). C57BL/6 mice fed EtOH-containing diet showed a mixed induction of hepatic classical (M1) and alternative (M2) macrophage markers. Since telomerase activation occurs at critical stages of myeloid and lymphoid cell activation, we herein investigated the role of telomerase reverse transcriptase (TERT), the determining factor of telomerase, in macrophage activation during ALD. In our study, TERT expression and telomerase activity (TA) were remarkably increased in liver tissue of EtOH-fed mice. Moreover, EtOH significantly up-regulated TERT in isolated KCs and RAW 264.7 cells and LPS induced TERT production in vitro. These data indicate that up-regulation of TERT may play a critical role in macrophages during ALD. Furthermore, loss- and gain-of-function studies suggested that TERT switched macrophages towards M1 phenotype by regulating NF-κB signaling, but had limited effect on M2 macrophages polarization in vitro. Additionally, PDTC, a chemical inhibitor of NF-κB, could dramatically down-regulate TERT expression and the hallmarks of M1 macrophages. Therefore, our study unveils the role of TERT in macrophage polarization and the cross-talk between TERT and p65, which may provide a possible explanation for the ethanol-mediated hepatic proinflammatory response and M1 macrophage polarization.
Figures








Similar articles
-
Effect of modulation of PPAR-γ activity on Kupffer cells M1/M2 polarization in the development of non-alcoholic fatty liver disease.Sci Rep. 2017 Mar 16;7:44612. doi: 10.1038/srep44612. Sci Rep. 2017. PMID: 28300213 Free PMC article.
-
MicroRNA-216a promotes M1 macrophages polarization and atherosclerosis progression by activating telomerase via the Smad3/NF-κB pathway.Biochim Biophys Acta Mol Basis Dis. 2019 Jul 1;1865(7):1772-1781. doi: 10.1016/j.bbadis.2018.06.016. Epub 2018 Jun 27. Biochim Biophys Acta Mol Basis Dis. 2019. PMID: 29940270
-
Regulation of lipid-induced macrophage polarization through modulating peroxisome proliferator-activated receptor-gamma activity affects hepatic lipid metabolism via a Toll-like receptor 4/NF-κB signaling pathway.J Gastroenterol Hepatol. 2020 Nov;35(11):1998-2008. doi: 10.1111/jgh.15025. Epub 2020 Mar 18. J Gastroenterol Hepatol. 2020. PMID: 32128893
-
Feedback regulation of telomerase reverse transcriptase: new insight into the evolving field of telomerase in cancer.Cell Signal. 2013 Dec;25(12):2462-8. doi: 10.1016/j.cellsig.2013.08.009. Epub 2013 Aug 29. Cell Signal. 2013. PMID: 23993966 Review.
-
Noncanonical functions of telomerase: implications in telomerase-targeted cancer therapies.Cancer Res. 2014 Mar 15;74(6):1639-44. doi: 10.1158/0008-5472.CAN-13-3568. Epub 2014 Mar 5. Cancer Res. 2014. PMID: 24599132 Review.
Cited by
-
TSG-6 Inhibits Oxidative Stress and Induces M2 Polarization of Hepatic Macrophages in Mice With Alcoholic Hepatitis via Suppression of STAT3 Activation.Front Pharmacol. 2020 Feb 4;11:10. doi: 10.3389/fphar.2020.00010. eCollection 2020. Front Pharmacol. 2020. PMID: 32116692 Free PMC article.
-
β-Arrestin 2 Promotes Hepatocyte Apoptosis by Inhibiting Akt Pathway in Alcoholic Liver Disease.Front Pharmacol. 2018 Sep 19;9:1031. doi: 10.3389/fphar.2018.01031. eCollection 2018. Front Pharmacol. 2018. PMID: 30283336 Free PMC article.
-
miR-203 Inhibits Alcohol-Induced Hepatic Steatosis by Targeting Lipin1.Front Pharmacol. 2018 Apr 4;9:275. doi: 10.3389/fphar.2018.00275. eCollection 2018. Front Pharmacol. 2018. PMID: 29670525 Free PMC article.
-
Ongoing involvers and promising therapeutic targets of hepatic fibrosis: The hepatic immune microenvironment.Front Immunol. 2023 Feb 16;14:1131588. doi: 10.3389/fimmu.2023.1131588. eCollection 2023. Front Immunol. 2023. PMID: 36875101 Free PMC article. Review.
-
Recent Insights Into the Role of Immune Cells in Alcoholic Liver Disease.Front Immunol. 2019 Jun 12;10:1328. doi: 10.3389/fimmu.2019.01328. eCollection 2019. Front Immunol. 2019. PMID: 31244862 Free PMC article. Review.
References
-
- Rehm J. et al. Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. Lancet 373, 2223–2233 (2009). - PubMed
-
- Louvet A. & Mathurin P. Alcoholic liver disease: mechanisms of injury and targeted treatment. Nat Rev Gastroenterol Hepatol 12, 231–242 (2015). - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources